Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J. Cullen; EMCDDA DRID Group; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V. Lazarus; Vivian D. Hope; Catharina Mathei; Sharon Hutchinson

doi:10.1371/journal.pone.0103345

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Lucas Wiessing, Marica Ferri, Bart Grady, Maria Kantzanou, Ida Sperle, Katelyn J. Cullen, EMCDDA DRID Group, Angelos Hatzakis, Maria Prins, Peter Vickerman, Jeffrey V. Lazarus, Vivian D. Hope, Catharina Mathei, Sharon Hutchinson

SHLS School Office

Research output: Contribution to journal › Article › peer-review

165 Downloads (Pure)

Abstract

People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.

Original language	English
Article number	e103345
Number of pages	20
Journal	PLoS ONE
Volume	9
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0103345
Publication status	Published - 28 Jul 2014

Keywords

people who inject drugs
PWID
hepatitis C
HCV epidemiology
Europe

Documents and Links

10.1371/journal.pone.0103345

Wiessing, L. et al (2014) Hepatitis c virus infection epidemiology among people who inject drugs in europe
This is the final published version of an article published in PLOS ONE. Available at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103345 Copyright: 2014 Wiessing et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Final published version, 983 KBLicence: CC BY

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103345#s5

Fingerprint Dive into the research topics of 'Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention'. Together they form a unique fingerprint.

Cite this

Wiessing, L., Ferri, M., Grady, B., Kantzanou, M., Sperle, I., Cullen, K. J., EMCDDA DRID Group, Hatzakis, A., Prins, M., Vickerman, P., Lazarus, J. V., Hope, V. D., Mathei, C., & Hutchinson, S. (2014). Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS ONE , 9(7), [e103345]. https://doi.org/10.1371/journal.pone.0103345

Wiessing, Lucas ; Ferri, Marica ; Grady, Bart ; Kantzanou, Maria ; Sperle, Ida ; Cullen, Katelyn J. ; EMCDDA DRID Group ; Hatzakis, Angelos ; Prins, Maria ; Vickerman, Peter ; Lazarus, Jeffrey V. ; Hope, Vivian D. ; Mathei, Catharina ; Hutchinson, Sharon. / Hepatitis C virus infection epidemiology among people who inject drugs in Europe : a systematic review of data for scaling up treatment and prevention. In: PLoS ONE . 2014 ; Vol. 9, No. 7.

@article{3c54139b50184e21ad0e88a4d4a23f97,

title = "Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention",

abstract = "People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.",

keywords = "people who inject drugs, PWID, hepatitis C, HCV epidemiology, Europe",

author = "Lucas Wiessing and Marica Ferri and Bart Grady and Maria Kantzanou and Ida Sperle and Cullen, {Katelyn J.} and {EMCDDA DRID Group} and Angelos Hatzakis and Maria Prins and Peter Vickerman and Lazarus, {Jeffrey V.} and Hope, {Vivian D.} and Catharina Mathei and Sharon Hutchinson",

note = "HH: 07dec15: article published but document attached to record. updated as much as possible. Author is part of the EMCDDA DRID Group, see Acknowledgements section for Contributors listing. Date of acceptance: 29/06/2014",

year = "2014",

month = jul,

day = "28",

doi = "10.1371/journal.pone.0103345",

language = "English",

volume = "9",

journal = "PLoS ONE ",

issn = "1932-6203",

publisher = "PLOS",

number = "7",

}

Wiessing, L, Ferri, M, Grady, B, Kantzanou, M, Sperle, I, Cullen, KJ, EMCDDA DRID Group, Hatzakis, A, Prins, M, Vickerman, P, Lazarus, JV, Hope, VD, Mathei, C & Hutchinson, S 2014, 'Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention', PLoS ONE , vol. 9, no. 7, e103345. https://doi.org/10.1371/journal.pone.0103345

Hepatitis C virus infection epidemiology among people who inject drugs in Europe : a systematic review of data for scaling up treatment and prevention. / Wiessing, Lucas; Ferri, Marica; Grady, Bart; Kantzanou, Maria; Sperle, Ida; Cullen, Katelyn J.; EMCDDA DRID Group; Hatzakis, Angelos; Prins, Maria; Vickerman, Peter; Lazarus, Jeffrey V.; Hope, Vivian D.; Mathei, Catharina; Hutchinson, Sharon.

In: PLoS ONE , Vol. 9, No. 7, e103345, 28.07.2014.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Hepatitis C virus infection epidemiology among people who inject drugs in Europe

T2 - a systematic review of data for scaling up treatment and prevention

AU - Wiessing, Lucas

AU - Ferri, Marica

AU - Grady, Bart

AU - Kantzanou, Maria

AU - Sperle, Ida

AU - Cullen, Katelyn J.

AU - EMCDDA DRID Group

AU - Hatzakis, Angelos

AU - Prins, Maria

AU - Vickerman, Peter

AU - Lazarus, Jeffrey V.

AU - Hope, Vivian D.

AU - Mathei, Catharina

AU - Hutchinson, Sharon

N1 - HH: 07dec15: article published but document attached to record. updated as much as possible. Author is part of the EMCDDA DRID Group, see Acknowledgements section for Contributors listing. Date of acceptance: 29/06/2014

PY - 2014/7/28

Y1 - 2014/7/28

N2 - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.

AB - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.

KW - people who inject drugs

KW - PWID

KW - hepatitis C

KW - HCV epidemiology

KW - Europe

U2 - 10.1371/journal.pone.0103345

DO - 10.1371/journal.pone.0103345

M3 - Article

VL - 9

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 7

M1 - e103345

ER -